Physician profile

Anthony Paterno

Chapel Hill, NC

NPI 1164160891

$3,927.62

in general payments reported to CMS, 2019-2025

4 companies · $3,081 in 2025

The $3,081 reported for 2025 was more than what 96% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$1,900.00
Food and Beverage$1,236.47
Travel and Lodging$700.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $3,309.92 2022-2025 T2, Gamma, Axsos
Innovation Technologies INC $419.56 2023-2024 Irrisept
Medtronic, INC. $178.59 2023-2024 Unid_pass, Cd Horizon Spinal System
Tricoast Surgical Solutions LLC $19.55 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anthony Paterno

$3,927.62

in general payments reported 2019-2025

Years
2022-2025
Top company
Stryker Corporation
Context
The $3,081 reported for 2025 was more than what 96% of providers received nationally.

https://glasscript.com/doctor/11428432/anthony-paterno

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.